MedTrace Logo

Clinical Observation of Renal Function Reactivation Following a GRAS-Based Protocol in Patients With Chronic Kidney Disease and Long-Term Renal Arrest.

NCT07555327 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2026-04-29

No results posted yet for this study

Summary

This observational study documents the impact of a specific oral protocol (based on FDA-GRAS ingredients) on patients with Stage 5 Chronic Kidney Disease (CKD). The study observes 8 participants, including 6 with residual renal function and 2 patients with long-term total renal arrest (16 years and 22 years of anuria). The primary focus is monitoring the restoration of urine output and changes in renal biological markers.

Conditions

  • End-Stage Renal Disease (ESRD) Chronic Kidney Disease, Stage 5 Renal Regeneration Anuria Diabetic Nephropathy
  • Anuria
  • End-Stage Renal Disease (ESRD)
  • Chronic Kidney Disease, Stage 5
  • Renal Regeneration

Interventions

DIETARY_SUPPLEMENT

CSR-CKD Oral Protocol

A specific oral nutritional intervention consisting of synergistic FDA-GRAS (Generally Recognized As Safe) components designed to support renal tissue recovery and restoration of urine output.

Sponsors & Collaborators

  • Amar h Zireg

    lead OTHER

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-02
Primary Completion
2026-04-15
Completion
2026-04-30

Countries

  • Algeria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07555327 on ClinicalTrials.gov